Nektar Therapeutics Net Non-Operating Interest Income Expense (Quarterly) Insights

Nektar Therapeutics (NKTR)

67.50 -2.87 (-4.08%) USD | NASDAQ | Feb 26, 15:11

View Net Non-Operating Interest Income Expense (Quarterly) for NKTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Rigel Pharmaceuticals, Inc.	Upgrade
Insmed, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
Lyell Immunopharma, Inc.	Upgrade